Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection
2021 · Nature Medicine · 4,152 citations
https://doi.org/10.1038/s41591-021-01377-8
A
Arnold Reynaldi
UNSW Sydney(AU)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
83
Papers
8.7K
Citations
30
h-index
48
i10-index
Arnold Reynaldi is an academic researcher from UNSW Sydney. The author has contributed to research in topics: SARS-CoV-2 and COVID-19 Research & COVID-19 Clinical Research Studies & T-cell and B-cell Immunology. The author has an h-index of 30, co-authored 71 publications.
ORCID: 0000-0002-5529-5542Papers by this author
worksPredicting vaccine effectiveness against severe COVID-19 over time and against variants: a meta-analysis
2023 · Nature Communications · 119 citations
https://doi.org/10.1038/s41467-023-37176-7
Macrophages direct location-dependent recall of B cell memory to vaccination
2025 · Cell · 14 citations
https://doi.org/10.1016/j.cell.2025.04.005
Predicting COVID-19 booster immunogenicity against future SARS-CoV-2 variants and the benefits of vaccine updates
2024 · Nature Communications · 12 citations
https://doi.org/10.1038/s41467-024-52194-9
B-cell characteristics define HCV reinfection outcome
2024 · Journal of Hepatology · 8 citations
https://doi.org/10.1016/j.jhep.2024.04.004
Bivalent mRNA booster vaccination recalls cellular and antibody immunity against antigenically divergent SARS-CoV-2 spike antigens
2025 · npj Vaccines · 5 citations
https://doi.org/10.1038/s41541-025-01129-6
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat